Concepedia

Ermes Vanotti

EV

Statistics

Publications

19

Citations

1.3K

H-Index

16

Active since

1979

Affiliations

Nerviano Medical Sciences(Current)

University of Milan

Ollscoil na Gaillimhe – University of Galway

Ermes Vanotti is an author at Nerviano Medical Sciences specializing in medicinal chemistry, drug discovery, and synthetic medicinal chemistry.

Publications per year

1979–2016

19

Publications

19

Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor

Maria Menichincheri, Elena Ardini, Paola Magnaghi et al. · Journal of Medicinal Chemistry · 2016 · 298 citations · Full text

, , +17

A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity

Alessia Montagnoli, Barbara Valsasina, Valter Croci et al. · Nature Chemical Biology · 2008 · 215 citations · Full text

, , +14

Synthesis and Immunosuppressive Activity of Novel Prodigiosin Derivatives

Roberto D’Alessio, Alberto Bargiotti, Orlando Carlini et al. · Journal of Medicinal Chemistry · 2000 · 161 citations

, , +11

Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potential Antitumor Agents. 1. Synthesis and Structure–Activity Relationships

Ermes Vanotti, Raffaella Amici, Alberto Bargiotti et al. · Journal of Medicinal Chemistry · 2008 · 94 citations · Full text

, , +13

First Cdc7 Kinase Inhibitors: Pyrrolopyridinones as Potent and Orally Active Antitumor Agents. 2. Lead Discovery

Maria Menichincheri, Alberto Bargiotti, Jens Berthelsen et al. · Journal of Medicinal Chemistry · 2008 · 67 citations · Full text

, , +13

1–5 of 19